S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7232 −0.27%
CLOSED · 17:35 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead
AB
INSIDER · KYMR · Kymera Therapeutics, Inc. · CHIEF LEGAL OFFICER

Adams Brian

Every open-market transaction filed under this name, Sep 4 to Sep 4.

Filings
3
0 buys · 3 sells
Bought
open market, at cost
Sold
$744K
includes scheduled sales
Buys since
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 4KYMRKymera Therapeutics, Inc.Chief Legal OfficerSell2,137$117.57$251K−0.2%
Sep 4KYMRKymera Therapeutics, Inc.Chief Legal OfficerSell3,025$116.81$353K+0.5%
Sep 4KYMRKymera Therapeutics, Inc.Chief Legal OfficerSell1,209$115.55$140K+1.6%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.